StreetAlpha.app
Home › Stocks › AVR

Anteris Technologies Global Corp. (AVR)

Healthcare
$5.32
▼ −6.67%
LAST CLOSE · NOV 17

Anteris Technologies develops the DurAVR THV System, a heart valve for patients with aortic stenosis, for cardiologists and surgeons. It last closed at $5.32 on Nov 17, down 6.67% on the day.

AI Auto Pilots
Is AVR in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$2.3M
+9.0% vs a year ago
Net income
−$108.1M
−4637.5% margin
EPS (diluted)
−$1.60
Free cash flow
−$93.5M
−4008.4% margin
Valuation
Market cap
$518.7M
97.5M shares
P/E
–
No P/E while losing money
Price to sales
222.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$217.0M
At Sep 30
Shareholder equity
$226.8M
Shares outstanding
97.5M
At Nov 9
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2024: $2.7M$2.7MFY2024FY2025: $1.9M$1.9MFY2025

From AVR's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Hold
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Hold
1firm
0 Buy1 Hold0 Sell
Only 1 firm rated AVR in the past 90 days, not enough for a consensus
Average 12-month target
$9.00
▲ 69.2% upside

Based on 1 analyst who set a price target on AVR in the past 90 days. The average target is $9.00, with a high of $9.00 and a low of $9.00, compared with the last close of $5.32.

Low $9.00Avg $9.00High $9.00
Blue marker: last close $5.32
Highest target$9.00
Average target$9.00
Lowest target$9.00
Latest rating changes
BarclaysTarget lowered
Nov 13Hold$10 → $9
BarclaysInitiated
Oct 7Hold$10
Cantor FitzgeraldReiterated
Aug 14Buy$15
DateFirmActionRatingPrice target
Nov 13BarclaysTarget loweredHold$10 → $9
Oct 7BarclaysInitiatedHold$10
Aug 14Cantor FitzgeraldReiteratedBuy$15
Loading…

Technical Analysis

AVR · as of the Nov 17 close · updated after every close
Downtrend

The stock is 11% below its 20 day and 28% below its 50 day average. It is 39% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 38). The nearest support is the swing low (Nov 2) at $5.25, and the nearest resistance the Pivot at $5.43.

Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 7.5%/day
Key levels
$11.0652 week high+107.9%
$7.87100 day average+47.9%
$7.37200 day average+38.5%
$6.8350 day average+28.4%
$6.26Swing high (Nov 12)+17.7%
$5.8820 day average+10.5%
$5.55Pivot R1+4.3%
$5.43Pivot+2.1%
$5.32Last close
$5.25Swing low (Nov 2)−1.3%
$5.19Pivot S1−2.4%
$3.3052 week low−38.0%
Indicators
RSI (14)38.04Weak, oversold below 30Neutral
MACD-0.33Above its signal lineBullish
Stochastic17.2Near the bottom of its rangeOversold
ADX (14)27.8Trending down
Williams %R-95.0Oversold below −80, overbought above −20Oversold
CCI (20)-169.6Oversold below −100, overbought above 100Oversold
Rate of change−5.0%Change over 10 sessionsBearish
ATR (14)$0.40Typical daily range, 7.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for AVR

What happened before

See how AVR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in AVR in the last 90 days.

Loading…

See today’s whale options flow across the market →

AVR Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼57 buying vs 69 selling
  • ▼Held by funds -4.3 pts
  • ●Funds holding +0
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1361360.0%
In funds' top 1023−33.3%
Held by funds66.5%70.8%−4.3 pts
New / increased20 / 3728 / 56−32.1%
Reduced / sold out48 / 2135 / 17+32.7%
Put/call ratio–0.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See AVR institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AVR is in one of them and how their past AVR trades turned out.

AVR in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered AVR in an article yet. Here's the latest on the wider market.

About Anteris Technologies Global

Anteris Technologies is a structural heart company based in Eagan, Minnesota. Its main product is the DurAVR THV System, a single piece transcatheter heart valve for patients with aortic stenosis, a narrowing of the aortic valve. The valve is delivered with a balloon expandable system and is intended for use by heart specialists and surgeons who treat these patients. The DurAVR is not yet approved for commercial sale in the United States or Europe and is being studied in clinical trials.

Headquarters
Eagan, MN